Vaccination

The vaccination is the most effective way to prevent infectious diseases. It allows us to protect ourselves and our fellow citizens. Thanks to the joint efforts of the global medical community, we are now fortunate to have access to SARS-CoV-2 vaccines. This is an essential element in the fight against COVID-19 and will help us stem the pandemic and its effects on our health and society.

Luxembourg's COVID-19 vaccination strategy supports access to and availability of safe and effective vaccines as soon as they are made available on the market.

This will mitigate the health, social and economic consequences of the COVID 19 pandemic. The vaccine will help save lives and make the best use of our resources.

It remains important to follow hygiene rules and wear a mask during the implementation of the vaccination strategy.

Vaccination strategy

In an initial phase, the vaccine is not available in sufficient doses for everyone to be vaccinated at the same time. It is therefore necessary and legitimate to prioritise according to the objectives of the immunisation strategy, i.e.

  1. protect the most vulnerable residents (based on their age or health status) from the risk of complications from the disease and from the risk of death, and
  2. protect the capacity of our health care system.

We are currently in phase 5.

Who will be vaccinated in phase 1?

Health care professionals and staff working in hospitals and residential facilities for the elderly are among those most exposed to COVID-19, and therefore deserve close protection, also with a view to forming a cordon sanitaire around infected persons.

Similarly, people living in residential facilities for the elderly will be vaccinated as a priority during this first phase. Indeed, age and the presence of co-morbidities are risk factors.

Who will be vaccinated in phase 2?

In phase 2, the following groups of people will be vaccinated:

Phase 2a: People who are highly vulnerable because of their age

  • People from the age of 75 years, starting with the oldest

Phase 2b: People who are highly vulnerable due to a pre-existing health condition

  • People with trisomy 21, adults
  • Solid organ transplants, including people on a waiting list who have undergone a hematopoietic stem cell transplant within the first 6 months or under immunosuppressive treatment
  • People with cancer or malignant hemopathy undergoing treatment (chemotherapy, radiotherapy, immunotherapy)
  • People with congenital immunodeficiencies

People suffering from a cancerous pathology and regularly followed in one of the country's oncology departments will be invited directly by the hospital in which they are treated to be vaccinated. Other people considered highly vulnerable will be able to be registered for vaccination via their general practitioner or specialist doctor as of 1st March and will then receive an invitation by post. These patients can also be vaccinated at the hospital. 

Who will be vaccinated in phase 3?

In phase 3, the following groups of people will be vaccinated:

Phase 3a: People who are significantly vulnerable because of their age

  • People between 70 and 74 years old, starting with the oldest

Phase 3b: People who are significantly vulnerable due to a pre-existing health condition

  • People suffering from acquired immunodeficiency: immunosuppressive medication, biotherapy and/or long-term corticosteroid therapy at immunosuppressive doses
  • People with one of the following factors:
    • HIV infection with CD4 <200/mm3
    • Asplenia, functional or not
    • Severe chronic respiratory disease
    • Severe chronic obstructive pulmonary disease (COPD), GOLD stages 3 and 4, group D*
    • Cystic fibrosis
    • Severe chronic pulmonary fibrosis
    • Severe restrictive extrapulmonary disease, with or without ventilation support.
    • Severe uncontrolled asthma (level 5 according to GINA) corticosteroid-dependent (under oral corticosteroid therapy)
  • Severe cardiovascular disease:
    • Cardiac insufficiency NYHA stage III or IV
    • Unstable coronary heart disease
    • Cardiomyopathy
  • Major neurocognitive deficiency (MMSE score < 20)
  • Chronic renal failure on dialysis
  • Stage B or C cirrhosis in the Child-Pugh score
  • Morbid obesity (body mass index > 40 kg/m2)

The people concerned by phase 3a, i.e. those over 70 years of age, will receive an invitation from the Ministry of Health by post, with detailed instructions on how to make an appointment in the vaccination centre of their choice. Personalised assistance is also offered through a hotline specifically set up for this purpose under the number (+352) 247-65533.

People considered significantly vulnerable according to the phase 3b definition will be able to register for the vaccination via their general practitioner or specialist doctor from the end of next week and will then receive an invitation by post.

Who will be vaccinated in phase 4?

In phase 4, the following groups of people will be vaccinated:

Phase 4a: People who are moderately vulnerable because of their age

  • People aged 65 to 69 (starting with the oldest)

Phase 4b: People who are moderately vulnerable due to pre-existing health conditions

  • People with one of the following factors:
    • Diabetes with or without insulin, with cardio-neurovascular complications
    • Complicated arterial hypertension with sequelae resulting from a stroke or associated heart disease
    • Neuromuscular disease with clinical repercussions

The people concerned by phase 4a, i.e. those between 65 and 69 years of age, will receive an invitation from the Ministry of Health by post, with detailed instructions on how to make an appointment in the vaccination centre of their choice. Personalised assistance is also offered through a hotline specifically set up for this purpose under the number (+352) 247-65533.

People considered moderately vulnerable as defined in phase 4b will be able to be registered for vaccination via their general practitioner or specialist doctor from 1 April and will then receive an invitation by post. ​

Who will be vaccinated in phase 5?

In phase 5, the following groups of people will be vaccinated:

Phase 5a: People aged 55-64 years, starting with the oldest

Phase 5b: People who have a health condition that may expose them to increased risk

  • People with one of the following factors:
    • Controlled diabetes, without complications
    • Uncomplicated arterial hypertension
    • Obesity (body mass index 30-40 kg/m2)
    • Pregnancy

The people concerned by phase 5a, i.e. those aged 55 - 64 years, will receive an invitation from the Ministry of Health by post, with detailed instructions on how to make an appointment in one of the vaccination centres of their choice. Personalised assistance is also offered through a hotline specifically set up for this purpose under the number (+352) 247-65533.

People with a health condition that may put them at increased risk as defined in phase 5b can be registered for vaccination through their personal physician or specialist doctor from 8 April and will then receive an invitation by post.

Invitations will be sent out as and when vaccines are delivered. 

Who will be vaccinated in phase 6?

Phase 6a: Specific categories of the general population

  • People living in precarious conditions, in communities, and who have not previously been vaccinated because of their vulnerability
  • Other people who are particularly exposed to contracting an infection as a result of their occupation

Phase 6b: General resident population

  • General resident population between 16 and 54 years of age, starting with the oldest, who have not been previously vaccinated due to vulnerability
For all documents about vaccination: click here

Daily situation update

  • 159.110 Total vaccines administered

  • 113.942 Total dose 1

  • 45.168 Total dose 2

  • 5.686 Vaccinations per day

    Dose 1: 3.505
    Dose 2: 2.181

I'm getting vaccinated! And you? Join in and send your photo!
Click here to participate

Last update